Editorial Material
Microbiology
Brianna M. Eales, Vincent H. Tam
Summary: This article presents a challenging case of ventilator-associated pneumonia in which bacteriophage therapy was used as a last resort treatment in combination with systemic antibiotics. The data are promising, and several key areas for future research are highlighted.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Article
Infectious Diseases
Subhankar Mukhopadhyay, Pengfei Zhang, Kenneth K. W. To, Yannan Liu, Changqing Bai, Sharon S. Y. Leung
Summary: Bacteriophage therapy, utilizing phages as natural enemies of bacteria, is being reintroduced to treat multidrug-resistant bacterial infections. However, the narrow host spectrum and rapid emergence of resistance limit their clinical use. Therefore, the combination of phages and antibiotics, known as phage-antibiotic synergy (PAS), is proposed. This study utilized an Acinetobacter baumannii phage and colistin as a model to investigate the impact of treatment order on PAS. The results showed that simultaneous application of phage and antibiotic effectively suppressed the development of resistance and demonstrated superior antibacterial and antibiofilm activities.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
(2023)
Review
Immunology
Chunli Sun, Yunsong Yu, Xiaoting Hua
Summary: Acinetobacter baumannii is a common pathogen causing various infectious diseases and has a high drug resistance rate, severely limiting antibiotic treatment options. Tigecycline and polymyxins are considered the last line of defense against multidrug resistant A. baumannii. This review focuses on the mechanisms of tigecycline resistance in A. baumannii and highlights the need for further investigation and development of new antibiotics.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2023)
Editorial Material
Microbiology
Santiago Castillo-Ramirez
Summary: A recent study published in mBio sequenced the genomes of 313 carbapenem-resistant A. baumannii isolates from over 100 hospitals in almost 50 countries, providing an updated view of the global distribution of major international clones and their carbapenemase genes. Future global genomic epidemiology studies can be enhanced by considering both human and non-human isolates and their antibiotic resistance profiles.
Review
Virology
Qihang Tu, Mingfang Pu, Yahao Li, Yuer Wang, Maochen Li, Lihua Song, Mengzhe Li, Xiaoping An, Huahao Fan, Yigang Tong
Summary: This paper describes the different drug resistances and basic properties of Acinetobacter baumannii (A. baumannii), and analyzes the interaction between phages and their hosts. It also focuses on A. baumannii phage therapies, discussing the chance and challenge of phage therapy. The aim of this paper is to provide a more comprehensive understanding of A. baumannii phages and theoretical support for their clinical application.
Article
Microbiology
Marco Falcone, Giusy Tiseo, Alessandro Leonildi, Leonardo Della Sala, Alessandra Vecchione, Simona Barnini, Alessio Farcomeni, Francesco Menichetti
Summary: Cefiderocol appears to be a promising therapeutic option for carbapenem-resistant Acinetobacter baumannii (CRAB) infections, with a potential protective effect on 30-day mortality. However, further studies are needed to address the issue of microbiological failure.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Article
Microbiology
Greater Kayode Oyejobi, Sunday Olabode Olaniyan, Nana-Aishat Yusuf, Deborah Adepeju Ojewande, Mobolaji Johnson Awopetu, Goodness Opeyemi Oyeniran, Fazal Mehmood Khan, Peter Alabi Dare, Maryam Kikelomo Adegbite-Badmus
Summary: Acinetobacter baumannii is an important nosocomial and opportunistic pathogen with high antibiotic resistance. New treatment approaches like the use of bacteriophage, phage-antibiotic combinations, and resistance-driven fitness losses are crucial for controlling its infections.
MICROBIOLOGICAL RESEARCH
(2022)
Article
Immunology
Michael J. McConnell, Antonio J. Martin-Galiano
Summary: This study utilized proteomic and computational data to identify a larger number of potentially immunogenic proteins in the Acinetobacter baumannii panproteome. The study found that certain antigens showed potential cross-reactivity with human proteins and were associated with different infection types. The integration of multi-omic data and knowledge of drug-resistant bacteria can aid in the development of effective multi-antigen vaccines against challenging infections.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Aminul Islam, Luis A. Actis, Timothy J. Wilson
Summary: This study reveals that natural antibodies (NAbs) enhance the host's immune response against A. baumannii infection, potentially leading to the development of effective therapies for human infections caused by antibiotic-resistant A. baumannii.
JOURNAL OF INFECTIOUS DISEASES
(2023)
Article
Microbiology
Aamir Hussain, Ihsan Ullah, Muhammad Q. Saeed
Summary: This study conducted a detailed analysis of the testing of bacteriophages against Acinetobacter baumannii using a murine model. The efficacy of these bacteriophages in healing wounds infected with multidrug resistant A. baumannii was assessed, as well as any potential impact on hematological parameters and liver and kidney function. The study also examined histological changes in hepatic and renal tissues of the treated animals. The results showed that the isolated lytic bacteriophage effectively promoted wound healing in the infected animals without causing significant changes in hematological or renal and hepatic profile. Histology of renal and hepatic tissues also remained normal. Overall, the study concluded that the isolated phage could be a promising therapeutic option against the deadly multidrug resistant A. baumannii.
JOURNAL OF BASIC MICROBIOLOGY
(2022)
Article
Virology
Gamaliel Lopez-Leal, Alejandro Reyes-Munoz, Rosa Isela Santamaria, Miguel A. Cevallos, Carlos Perez-Monter, Santiago Castillo-Ramirez
Summary: This study characterized a bacteriophage Ab11510-phi isolated from a multidrug-resistant Acinetobacter baumannii strain, revealing its narrow host range and classification within the Vieuvirus genus. Furthermore, the study highlighted the high level of mosaicism in Ab11510-phi and emphasized the importance of comparative genomics and phylogenetic analysis for proper characterization of phage diversity.
ARCHIVES OF VIROLOGY
(2021)
Article
Microbiology
David M. P. De Oliveira, Brian M. Forde, Minh-Duy Phan, Bernhard Steiner, Bing Zhang, Johannes Zuegg, Ibrahim M. El-deeb, Gen Li, Nadia Keller, Stephan Brouwer, Nichaela Harbison-Price, Amanda J. Cork, Michelle J. Bauer, Saleh F. Alquethamy, Scott A. Beatson, Jason A. Roberts, David L. Paterson, Alastair G. McEwan, Mark A. T. Blaskovich, Mark A. Schembri, Christopher A. McDevitt, Mark von Itzstein, Mark J. Walker
Summary: This study explores the use of PBT2 to break the resistance of A. baumannii to tetracycline class antibiotics, showing promising results in both in vitro and in vivo experiments.
Article
Microbiology
David M. P. De Oliveira, Brian M. Forde, Minh-Duy Phan, Bernhard Steiner, Bing Zhang, Johannes Zuegg, Ibrahim M. El-Deeb, Gen Li, Nadia Keller, Stephan Brouwer, Nichaela Harbison-Price, Amanda J. Cork, Michelle J. Bauer, Saleh F. Alquethamy, Scott A. Beatson, Jason A. Roberts, David L. Paterson, Alastair G. McEwan, Mark A. T. Blaskovich, Mark A. Schembri, Christopher A. McDevitt, Mark von Itzstein, Mark J. Walker
Summary: The study found that the combination of PBT2 and zinc with tetracycline class antibiotics can effectively combat multidrug-resistant A. baumannii, potentially serving as a treatment for overcoming strain resistance.
Article
Biotechnology & Applied Microbiology
Rosesathorn Soontarach, Ozioma Forstinus Nwabor, Supayang Piyawan Voravuthikunchai
Summary: This study found that the combination of specific phages and antibiotics can significantly reduce the biomass and bacterial viability of multidrug-resistant Acinetobacter baumannii biofilms. This is of great importance for the management of infections and elimination of bacterial biofilms.
Article
Medical Laboratory Technology
Ehsanollah Ghaznavi-Rad, Majid Komijani, Alireza Moradabadi, Marzieh Rezaei, Nima Shaykh-Baygloo
Summary: This study aimed to isolate, identify, and analyze a new lytic bacteriophage targeting extensively drug-resistant Acinetobacter baumannii. The results showed that the isolated phage exhibited high specificity, stability, and therapeutic efficacy in reducing lesion area in a rat model.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2022)
Article
Critical Care Medicine
Matthias Felten, Sebastian Ferencik, Luiz-Gustavo Teixeira Alves, Eleftheria Letsiou, Jasmin Lienau, Holger C. Mueller-Redetzky, Alina Katharina Langenhagen, Anne Voss, Kristina Dietert, Olivia Kershaw, Achim D. Gruber, Laura Michalick, Wolfgang M. Kuebler, Bharath Ananthasubramaniam, Bert Maier, Henriette Uhlenhaut, Achim Kramer, Martin Witzenrath
Summary: This study investigated the role of the core clock component BMAL1 in myeloid cells in modulating the severity of ventilator-induced lung injury (VILI). The results showed that inflammatory response and lung barrier dysfunction during mechanical ventilation exhibit diurnal variations regulated by the circadian clock. Mice without BMAL1 are less susceptible to VILI and do not show circadian variation in severity.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2023)
Letter
Respiratory System
Erik Asmus, Weronika Karle, Markus C. Brack, Corey Wittig, Felix Behrens, Leander Reinshagen, Moritz Pfeiffer, Sabrina Schulz, Bertina Mandzimba-Maloko, Lasti Erfinanda, Paul L. Perret, Laura Michalick, Patrick J. Smeele, Endry H. T. Lim, Charissa E. van den Brom, Alexander B. A. Vonk, Toralf Kaiser, Norbert Suttorp, Stefan Hippenstiel, Leif E. Sander, Florian Kurth, Ursula Rauch, Ulf Landmesser, Arash Haghikia, Robert Preissner, Harm J. Bogaard, Martin Witzenrath, Wolfgang M. Kuebler, Robert Szulcek, Szandor Simmons
EUROPEAN RESPIRATORY JOURNAL
(2023)
Article
Infectious Diseases
Anna Lena Jung, Malene Moller Jorgensen, Rikke Baek, Marie Artho, Kathrin Griss, Maria Han, Wilhelm Bertrams, Timm Greulich, Rembert Koczulla, Stefan Hippenstiel, Dominik Heider, Norbert Suttorp, Bernd Schmeck
Summary: Malaria is a life-threatening disease caused by Plasmodium parasites, mainly occurring in tropical and subtropical countries. Plasmodium falciparum is the most prevalent cause of malaria in Africa and responsible for most malaria-related deaths worldwide. This study found that certain proteins on plasma sEVs can differentiate between healthy individuals and malaria patients, suggesting their potential as predictive biomarkers.
Article
Biochemistry & Molecular Biology
Julia Figl, Heike Koehler, Nadine Wedlich, Elisabeth M. Liebler-Tenorio, Leander Grode, Gerald Parzmair, Gopinath Krishnamoorthy, Natalie E. Nieuwenhuizen, Stefan H. E. Kaufmann, Christian Menge
Summary: A more effective vaccine against tuberculosis is urgently needed. The recombinant vaccine VPM1002 has been found to be safer and more efficacious than the existing vaccine BCG in mice models. In this study, the safety and immunogenicity of VPM1002 and its derivatives, PDX and NUOG, were assessed in juvenile goats. The results showed that VPM1002 and NUOG induced anti-tuberculous immunity with a comparable safety profile to BCG.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Infectious Diseases
Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, Martin Kluge, Tobias Puengel, Muenevver Demir, Robert Roehle, Theresa Keller, Christoph Ruwwe-Gloesenkamp, Martin Witzenrath, Norbert Suttorp, Christof von Kalle, Leif E. Sander, Christoph Jochum, Frank Tacke
Summary: This study presents human data on the use of a chemokine receptor inhibitor, Cenicriviroc (CVC), in patients with COVID-19. The results demonstrate the efficacy of CVC in treating moderate to severe COVID-19 and its inhibitory effect on CCR2 and CCR5. However, further research is needed to evaluate the efficacy and safety of this drug.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
(2023)
Article
Microbiology
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, Stefan Peidli, Luiz Gustavo Teixeira Alves, Morris Baumgardt, Judith Bushe, Anne Voss, Alina Langenhagen, Christine Langner, Ricardo Martin Vidal, Fabian Pott, Julia Kazmierski, Aileen Ebenig, Mona V. Lange, Michael D. Muehlebach, Cengiz Goekeri, Szandor Simmons, Na Xing, Azza Abdelgawad, Susanne Herwig, Guenter Cichon, Daniela Niemeyer, Christian Drosten, Christine Goffinet, Markus Landthaler, Nils Bluethgen, Haibo Wu, Martin Witzenrath, Achim D. Gruber, Samantha D. Praktiknjo, Nikolaus Osterrieder, Emanuel Wyler, Dusan Kunec, Jakob Trimpert
Summary: In hamsters, compared the live-attenuated vaccine sCPD9, mRNA vaccine BNT162b2, and adenovirus-vectored vaccine with SARS-CoV-2 challenge, sCPD9 vaccine elicited the strongest immune response, including rapid viral clearance, reduced tissue damage, fast differentiation of pre-plasmablasts, strong systemic and mucosal humoral responses, and rapid recall of memory T cells from lung tissue after heterologous SARS-CoV-2 challenge.
NATURE MICROBIOLOGY
(2023)
Article
Cell Biology
Cengiz Goekeri, Peter Pennitz, Wibke Groenewald, Ulrike Behrendt, Holger M. Kirsten, Christian Zobel, Sarah A. Berger, Gitta Heinz, Mir-Farzin Mashreghi, Sandra-Maria Wienhold, Kristina Dietert, Anca D. Dorhoi, Achim Gruber, Markus Scholz, Gernot Rohde, Norbert Suttorp, Geraldine CAPNETZ Study Grp, Martin Witzenrath, Geraldine Nouailles
Summary: This study aimed to investigate the role of microRNA-223 in orchestrating pulmonary inflammation during pneumococcal pneumonia. It was found that low levels of serum microRNA-223 correlated with increased disease severity in patients. In murine experiments, the absence of microRNA-223 led to increased neutrophilic influx into the lungs, resulting in aggravated histopathology and acute lung injury.
Article
Medicine, General & Internal
Anna Lena Jung, Maria Han, Kathrin Griss, Wilhelm Bertrams, Christoph Nell, Timm Greulich, Andreas Klemmer, Hendrik Pott, Dominik Heider, Claus F. Vogelmeier, Stefan Hippenstiel, Norbert Suttorp, Bernd Schmeck
Summary: This study analyzed the value of selected plasma markers in the differential diagnosis and severity grading of community-acquired pneumonia (CAP) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The levels of certain markers were found to differ between CAP and AECOPD patients and healthy individuals. These markers can serve as biomarkers and provide information on differential diagnosis and disease severity.
FRONTIERS IN MEDICINE
(2023)
Article
Veterinary Sciences
Miriam Katsburg, Christiane Weingart, Etienne Aubry, Olivia Kershaw, Judith Kikhney, Laura Kursawe, Antina Luebke-Becker, Annette Moter, Marianne Skrodzki, Barbara Kohn, Marcus Fulde
Summary: An 8-year-old male Rhodesian Ridgeback presented with fever and severe thrombocytopenia. The dog was diagnosed with infective endocarditis, ischemic renal infarcts, and septic encephalitis. Despite immediate treatment, the condition worsened and the dog had to be euthanized. The causative Streptococcus canis strain was identified and analyzed, and a biofilm was found on the affected heart valve. Early diagnosis and research on optimal antibiotic dosages and biofilm-active drugs could improve treatment outcomes for endocarditis.
VETERINARY SCIENCES
(2023)
Article
Biochemical Research Methods
Peter Pennitz, Cengiz Goekeri, Jakob Trimpert, Emanuel Wyler, Aileen Ebenig, Chantal Weissfuss, Michael D. Muhlebach, Martin Witzenrath, Geraldine Nouailles
Summary: This article introduces a protocol for transforming solid and complex organs like the lungs into diverse, viable single-cell suspensions, and discusses the challenge of increasing the proportion of pulmonary endothelial cells without compromising viability.
Article
Cell Biology
Sara Timm, Marie Lettau, Jan Hegermann, Maria Linda Rocha, Sarah Weidenfeld, Diana Fatykhova, Birgitt Gutbier, Geraldine Nouailles, Elena Lopez-Rodriguez, Andreas Hocke, Stefan Hippenstiel, Martin Witzenrath, Wolfgang M. M. Kuebler, Matthias Ochs
Summary: Recent investigations have focused on the properties of glycocalyx in endothelial cells, while there is limited research on this complex structure in alveolar epithelial cells. In this study, the alveolar glycocalyx ultrastructure was characterized using transmission electron microscopy in human lung tissue and mouse lungs. The results demonstrate a reduction in glycocalyx components and density in response to treatment with heparinase or pneumolysin. This research provides quantitative data on the distribution of glycocalyx in alveolar epithelial cells and highlights the structural changes caused by glycocalyx shedding.
HISTOCHEMISTRY AND CELL BIOLOGY
(2023)
Article
Infectious Diseases
Benjamin Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, Florian Voit, Norbert Suttorp, Christoph Boesecke, Christian Hoffmann, Daiana Stolz, Mathias Pletz, Gernot Rohde, Martin Witzenrath, Marcus Panning, Andreas Essig, Jan Rupp, Olaf Degen, Christoph Stephan, M. Dreher
Summary: The objective of this study was to identify the pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH), and to compare it with a matched HIV negative group in order to reassess therapeutic strategies for PLWH. The study used various methods to identify pathogens, and found that pneumococci were the most common pathogen among both PLWH and controls. The mortality rate was higher for PLWH compared to controls.
Article
Infectious Diseases
Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, Yvonne Ahlgrimm, Ira An Haack, Dietrich August, Beate Balzuweit, Carla Bellinghausen, Sarah Berger, Irina Chaplinskaya-Sobol, Oliver Cornely, Patrick Doeblin, Matthias Endres, Claudia Fink, Carsten Finke, Sandra Frank, Sabine Hanss, Tim Hartung, Johannes Christian Hellmuth, Susanne Herold, Peter Heuschmann, Jan Heyckendorf, Ralf Heyder, Stefan Hippenstiel, Wolfgang Hoffmann, Sebastian Ulrich Kelle, Philipp Knape, Philipp Koehler, Lucie Kretzler, David Manuel Leistner, Jasmin Lienau, Roberto Lorbeer, Bettina Lorenz-Depiereux, Constanze Dorothea Luettke, Knut Mai, Uta Merle, Lil Antonia Meyer-Arndt, Olga Miljukov, Maximilian Muenchhoff, Moritz Mueller-Plathe, Julia Neuhann, Hannelore Neuhauser, Alexandra Nieters, Christian Otte, Daniel Pape, Rafaela Maria Pinto, Christina Pley, Annett Pudszuhn, Philipp Reuken, Siegberg Rieg, Petra Ritter, Gernot Rohde, Maria Roennefarth, Michael Ruzicka, Jens Schaller, Anne Schmidt, Sein Schmidt, Verena Schwachmeyer, Georg Schwanitz, Werner Seeger, Dana Stahl, Nicole Stobaeus, Hans Christian Stubbe, Norbert Suttorp, Bettina Temmesfeld, Sylvia Thun, Paul Triller, Frederik Trinkmann, Istvan Vadasz, Heike Valentin, Maria Vehreschild, Christof von Kalle, Marie von Lilienfeld-Toal, Joachim Weber, Tobias Welte, Christian Wildberg, Robert Wizimirski, Saskia Zvork, Leif Erik Sander, Janne Vehreschild, Thomas Zoller, Florian Kurth, Martin Witzenrath
Summary: The NAPKON-HAP study is a multi-centered observational study aimed at providing comprehensive data and biospecimen collection for the investigation of the pathophysiology and pathology of COVID-19. It will contribute significant scientific insights and high-quality data to aid researchers in understanding the acute and long-term outcomes of the disease.